Trial · NCT02552212
Participant flow24
How many started, completed or left each group, period by period.
1 to 20 of 24
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Double-Blind Period (Week 0 - 52) | STARTED | Placebo | 158 | |
| Double-Blind Period (Week 0 - 52) | STARTED | CZP 200 mg Q2W | 159 | |
| Double-Blind Period (Week 0 - 52) | STARTED | SFE OL CZP 200 mg Q2W | 0 | |
| Double-Blind Period (Week 0 - 52) | Received OL CZP | Placebo | 96 | |
| Double-Blind Period (Week 0 - 52) | Received OL CZP | CZP 200 mg Q2W | 20 | |
| Double-Blind Period (Week 0 - 52) | Received OL CZP | SFE OL CZP 200 mg Q2W | 0 | |
| Double-Blind Period (Week 0 - 52) | Completed Week 52 Without Starting SFE | Placebo | 20 | |
| Double-Blind Period (Week 0 - 52) | Completed Week 52 Without Starting SFE | CZP 200 mg Q2W | 22 | |
| Double-Blind Period (Week 0 - 52) | Completed Week 52 Without Starting SFE | SFE OL CZP 200 mg Q2W | 0 | |
| Double-Blind Period (Week 0 - 52) | COMPLETED | Placebo | 143 | |
| Double-Blind Period (Week 0 - 52) | COMPLETED | CZP 200 mg Q2W | 142 | |
| Double-Blind Period (Week 0 - 52) | COMPLETED | SFE OL CZP 200 mg Q2W | 0 | |
| Double-Blind Period (Week 0 - 52) | NOT COMPLETED | Placebo | 15 | |
| Double-Blind Period (Week 0 - 52) | NOT COMPLETED | CZP 200 mg Q2W | 17 | |
| Double-Blind Period (Week 0 - 52) | NOT COMPLETED | SFE OL CZP 200 mg Q2W | 0 | |
| SFE Period (Week 52 - 156) | STARTED | Placebo | 0 | |
| SFE Period (Week 52 - 156) | STARTED | CZP 200 mg Q2W | 0 | |
| SFE Period (Week 52 - 156) | STARTED | SFE OL CZP 200 mg Q2W | 243 | |
| SFE Period (Week 52 - 156) | COMPLETED | Placebo | 0 | |
| SFE Period (Week 52 - 156) | COMPLETED | CZP 200 mg Q2W | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02552212/flow